INDAPAMIDE KRKA LP 1.5 mg, extended-release film-coated tablet 30 tablets
Active ingredients: Indapamide
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release film-coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- INDAPAMIDE KRKA LP 1,5 mg, comprimé pelliculé à libération prolongée
- Pharmaceutical form
- comprimé pelliculé à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) aluminium PVC PVDC de 30 comprimé(s)
- Marketing authorisation holder
- KRKA (SLOVENIE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 5 Sept 2012
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60862062CIP73861547CIP133400938615470Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| INDAPAMIDEcomprimé | 1,5 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.